Align Technology Inc

ALGN remains in a Stage 2 advancing regime with a clear series of higher highs and higher lows. Price is pulling back into its rising 9- and 20-EMA zone within a neutral OB/OS context. Given the momentum + EPS strategy, selective shallow entries into the EMA support zone align with continuation bias, while patience is warranted until dynamic support is absorbed.

• ↑Q1 revenue $1.04B (+6.2% YoY) and aligner sales $856M (+7.4%).
• ↑Operating margin of 13.6% with $142M operating income.
• ↓Restructuring costs weigh on margins amid negative profitability factors.